Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD ...

Researchers randomized patients with advanced neuroendocrine tumors 2:1 to receive either cabozantinib or placebo.

The OHSU researchers call their test “PAC-MANN,” which stands for “protease activity-based assay using a magnetic nanosensor.

A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the ...

The problem with pancreatic cancer is that we often catch it too late,” he stated. The PAC-MANN test aims to enable ...

Cedars-Sinai investigators are developing a tool using artificial intelligence to help predict pancreatic cancer in Black ...

Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...

Mr Malone said his father had “asked me to help him kill himself” while he suffered with pancreatic cancer in hospital aged 85, something he “obviously” was not able to do. Mr Malone’s ...

Most patients with pancreatic cancer are diagnosed in late-stage ... TNM staging was performed according to American Joint Committee on Cancer and Union for International Cancer Control TNM on the ...

An enhanced model that integrates non-AJCC clinical features provides clinicians with a more accurate tool for identifying high-risk patients with MCC.

Disparities in clinical trial enrollment among LGBTQ+ individuals and its impact on cancer treatment and management: A systematic review. Contingency table showing frequencies (%) of cancer stages for ...

The 5-year relative survival rate is low at about 3%, and patients with advanced pancreatic cancer, who have a high recurrence rate, are now able to experience a new treatment method that ...